ArticleOncology letters2023

Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest

Yasuto Naoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.